Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
64
datasets available to search
ShareScore release 0.9.0
Dataset results
64 results for “direct acting antivirals”
A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
ClinicalTrials.gov study NCT02510300. IPD Sharing: YES. Countries: 9. Publications: 1.
HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial
ClinicalTrials.gov study NCT04653818. IPD Sharing: YES. Countries: 1. Publications: 1.
Direct Acting Antivirals for HCV Infection in Kidney Transplant Recipients
ClinicalTrials.gov study NCT03880682. IPD Sharing: NO. Countries: 1. Publications: 1.
Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial
Open the record for dataset details and reuse information.
Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy
ClinicalTrials.gov study NCT05717400. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epigenetic Changes in Hepatocellular Carcinoma Developed After Direct Acting Antiviral Therapy for Chronic Hepatitis C
ClinicalTrials.gov study NCT04220151. IPD Sharing: NO. Countries: 0. Publications: 4.
Integrated Care for Patients With High Risk Substance Use and Psychiatric Disorder With Chronic Direct Acting Antiviral Treatment
ClinicalTrials.gov study NCT02648022. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs
ClinicalTrials.gov study NCT03268317. IPD Sharing: Not stated. Countries: 0. Publications: 9.
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)-
ClinicalTrials.gov study NCT01168856. IPD Sharing: Not stated. Countries: 15. Publications: 0.
An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1
ClinicalTrials.gov study NCT01508130. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Frequency of Anxiety and Depression in Chronic Hepatitis C Patients Recieving Direct-Acting Antiviral Agents
ClinicalTrials.gov study NCT03894696. IPD Sharing: Not stated. Countries: 0. Publications: 16.
Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant
ClinicalTrials.gov study NCT03623568. IPD Sharing: YES. Countries: 1. Publications: 0.
Estimating the Net Value of Treating Hepatitis C Virus Using Newly Available Direct-Acting Antivirals in India (Supporting Datasets)
Open the record for dataset details and reuse information.
Hepatitis C Virus-induced Differential Transcriptional Traits in Host Cells After Persistent Infection Elimination by Direct-Acting Antivirals In Cell Culture
GEO Series GSE267834. Homo sapiens. 28 samples. Type: Expression profiling by high throughput sequencing.
Targeted respiratory expression of B3GAT1 as a broadly acting, host-directed antiviral strategy
GEO Series GSE205009. Homo sapiens. 8 samples. Type: Other.
The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects
ClinicalTrials.gov study NCT02581020. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant
ClinicalTrials.gov study NCT03093740. IPD Sharing: NO. Countries: 1. Publications: 0.
Side Effects After Direct-acting Antiviral Treatment
ClinicalTrials.gov study NCT03346941. IPD Sharing: NO. Countries: 1. Publications: 0.
Pilot HCV Direct Acting Antiviral Therapy and Metabolism
ClinicalTrials.gov study NCT02734173. IPD Sharing: YES. Countries: 1. Publications: 0.
The Effects of the Direct Acting Antiviral Agent Boceprevir on the Pharmacokinetics of Maraviroc in Healthy Volunteers
ClinicalTrials.gov study NCT01627717. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.